* InspireMD Inc NSPR.OQ reported a quarterly adjusted loss
of 16
cents per share for the quarter , lower than the same quarter
last year, when the company reported EPS of -15 cents. The lone
analyst forecast for the quarter was for a loss of 20 cents per
share.
* Revenue rose 16.3% to $1.81 million from a year ago;
analysts
expected $1.74 million.
* InspireMD Inc's reported EPS for the quarter was a loss
of 16
cents.
* The company reported a quarterly loss of $7.89 million.
* InspireMD Inc shares had fallen by 8.4% this quarter and
lost 12.6% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for InspireMD Inc is
4.50
This summary was machine generated from LSEG data November 12 at
03:35 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.20 -0.16 Beat
Jun. 30 2024 -0.19 -0.22 Missed
Mar. 31 2024 -0.15 -0.21 Missed
Dec. 31 2023 -0.19 -0.16 Beat